Nucleai, Mayo Clinic partner on digital pathology
June 8, 2023 -- Nucleai and Mayo Clinic BioPharma Diagnostics on Monday announced a strategic collaboration involving digital pathology solutions, technologies, and services to support drug development and clinical practice. Read More
Adaptive Biotechnologies, Genentech announce FDA acceptance of investigational new drug application
May 9, 2023 -- Adaptive Biotechnologies on Tuesday announced that the U.S. Food and Drug Administration (FDA) has accepted an investigational new drug (IND) application submitted by its collaborator, Genentech, for a neoantigen-directed T-cell receptor (TCR)-based T-cell therapy. Read More
Roche launches Institute of Human Biology for human model systems to advance research and drug development
May 5, 2023 -- Roche on Thursday announced the launch of the Institute of Human Biology (IHB), focused on advancing medical research through human model systems such as organoids. Using human model systems, the IHB aims to accelerate drug discovery and development through understanding how diseases develop and organs function. Read More
SomaLogic CEO steps down; Q4 revenue declines 18%
March 31, 2023 -- Aptamer-based proteomics firm SomaLogic said after the close of the market on Tuesday that its fourth-quarter revenue declined 18% year over year, primarily due to the recognition of $1.9 million of licensing revenue in the fourth quarter of 2021. Read More
1
Conferences
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter